AMED: Amedisys Inc. Company Profile & Statistics

About

Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).

Info & Links

CEO

Richard Ashworth

Headquarters

3854 AMERICAN WAY, SUITE A
BATON ROUGE, LA 70816, UNITED STATES

Auditor

KPMG LLP

Share holders

458

Employees

19,000

Amedisys Inc. Statistics

Valuation Measures

Market Capitalization²

2.77B

Enterprise Value

2.62B

Enterprise Value/EBITDA(ttm)

12.56

Price to Earnings Ratio(ttm)

19.53

Price to Sales(ttm)

1.18

Price to Book(mrq)

2.29

Price to Cash(ytd)

13.71

Profitability

Gross Margin(ttm)

43.67%

Operating Margin(ttm)

6.10%

Profit Margin(ttm)

3.56%

Return on Equity(ttm)

12.20%

Return on Invested Capital(ttm)

6.02%

Return on Assets(ttm)

6.74%

Income Statement

Revenue(ttm)

2.32B

Revenue Per Share(ttm)

70.87

Gross Profit(ttm)

1.01B

EBITDA(ttm)³

208.67M

Net Income Available to Common(ttm)

82.93M

Diluted EPS(ttm)

2.52

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

-9.63%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

32.75M

Dividend Yield

0.00%

Float⁴

32.07M

% Held by Insiders

2.10%

% Held by Institutions

94.36%

Balance Sheet

Total Cash(mrq)

245.45M

Total Cash Per Share(mrq)

7.49

Total Debt(mrq)

96.80M

Total Debt/Equity(mrq)

8.06%

Current Ratio(mrq)

1.19%

Quick Ratio(mrq)

1.19%

Book Value Per Share(mrq)

36.65

Cash Flow

Operating Cash Flow Per Share(ytd)

4.57

Free Cash Flow(ytd)

145.95M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AMED

Amedisys Inc.

Amedisys Inc. Profile